Decreased expression of a 40-kDa catecholamine-regulated protein in the ventral striatum of schizophrenic brain specimens from the Stanley Foundation Neuropathology Consortium

Schizophrenia Research

Volumn 74, Issue 1, 2005, Pages 111-119

  Gabriele, Joseph P ^a   Chong, Victor Z ^a   Pontoriero, Giuseppe F ^a   Mishra, Ram K ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Catecholamine regulated protein; Clozapine; Haloperidol; Schizophrenia; Ventral striatum

Indexed keywords

CATECHOLAMINE REGULATED HEAT SHOCK LIKE PROTEIN 40; CLOZAPINE; HALOPERIDOL; HEAT SHOCK PROTEIN 70; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CADAVER; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; FEMALE; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCHIZOPHRENIA; SEX DIFFERENCE; TISSUE LEVEL;

EID: 13444283559     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.03.025     Document Type: Article

References (23)

1. Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L.S., Weiss R., Cooper T.B., Mann J.J., Van Heertum R.L., Gorman J.M., Laruelle M. From the cover: increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8104-8109
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
3. Epstein J., Stern E., Silbersweig D. Mesolimbic activity associated with psychosis in schizophrenia. Symptom-specific PET studies. Ann. N.Y. Acad. Sci. 877:1999;562-574
4. Gabriele J., Rajaram M., Zhang B., Sharma S., Mishra R.K. Modulation of a 40-kDa catecholamine-regulated protein following D-amphetamine treatment in discrete brain regions. Eur. J. Pharmacol. 453:2002;13
5. Gabriele J., Culver K., Sharma S., Zhang B., Szechtman H., Mishra R.K. Asymmetric modulation of a catecholamine-regulated protein in the rat brain, following quinpirole administration. Synapse. 49:2003;261-269
6. Goto A., Doering L., Nair V.D., Mishra R.K. Immunohistochemical localization of a 40-kDa catecholamine regulated protein in the nigrostriatal pathway. Brain Res. 900:2001;314-319
7. Kapur S., Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: a new hypothesis. Am. J. Psychiatry. 158:2001;360-369
8. Karlsson P., Farde L., Halldin C., Sedvall G. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. Am. J. Psychiatry. 159:2002;761-767
9. Kasai K., Iwanami A., Yamasue H., Kuroki N., Nakagome K., Fukuda M. Neuroanatomy and neurophysiology in schizophrenia. Neurosci. Res. 43:2002;93-110
10. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
11. Lewis D.A., Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron. 28:2000;325-334
12. Macario A.J., Conway d.M. Sick chaperones and ageing: a perspective. Ageing Res. Rev. 1:2002;295-311
13. Marcotte E.R., Pearson D.M., Srivastava L.K. Animal models of schizophrenia: a critical review. J. Psychiatry Neurosci. 26:2001;395-410
14. Modi P.I., Kashyap A., Nair V.D., Ross G.M., Fu M., Savelli J.E., Marcotte E.R., Barlas C., Mishra R.K. Modulation of brain catecholamine absorbing proteins by dopaminergic agents. Eur. J. Pharmacol. 299:1996;213-220
15. Nair V.D., Mishra R.K. Molecular cloning, localization and characterization of a 40-kDa catecholamine-regulated protein. J. Neurochem. 76:2001;1142-1152
16. Ross G.M., McCarry B.E., Thakur S., Mishra R.K. Identification of novel catecholamine absorbing proteins in the central nervous system. J. Mol. Neurosci. 4:1993;141-148
17. Ross G.M., McCarry B.E., Mishra R.K. Covalent affinity labeling of brain catecholamine-absorbing proteins using a high-specific-activity substituted tetrahydronaphthalene. J. Neurochem. 65:1995;2783-2789
18. Seeman P., Kapur S. Clozapine occupies high levels of dopamine D2 receptors. Life Sci. 60:1997;L-16
19. Seeman P., Kapur S. Schizophrenia: more dopamine, more D2 receptors. Proc. Natl. Acad. Sci. U. S. A. 97:2000;7673-7675
20. Sharan N., Nair V.D., Mishra R.K. Modulation of a 40-kDa catecholamine regulated protein by dopamine receptor antagonists. Eur. J. Pharmacol. 413:2001;73-79
21. Sharan N., Chong V.Z., Nair V.D., Mishra R.K., Hayes R.J., Gardner E.L. Cocaine treatment increases expression of a 40 kDa catecholamine-regulated protein in discrete brain regions. Synapse. 47:2003;33-44
22. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 44:2000;151-155
23. Zakzanis K.K., Hansen K.T. Dopamine D2 densities and the schizophrenic brain. Schizophr. Res. 32:1998;201-206